Aptevo Therapeutics Inc. Income (Loss) from Continuing Operations, Per Basic Share
Aptevo Therapeutics Inc. (APVO) reported Income (Loss) from Continuing Operations, Per Basic Share of -$87.38 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2025-02-14
- Aptevo Therapeutics Inc. income (loss) from continuing operations, per basic share for the quarter ending 2024-09-30 was -$0.48.
- Aptevo Therapeutics Inc. income (loss) from continuing operations, per basic share for the quarter ending 2024-06-30 was -$1.67.
- Aptevo Therapeutics Inc. income (loss) from continuing operations, per basic share for the quarter ending 2024-03-31 was -$9.95, a 186.90% decline year-over-year.
- Aptevo Therapeutics Inc. income (loss) from continuing operations, per basic share for the quarter ending 2023-09-30 was -$22.16.
- Aptevo Therapeutics Inc. income (loss) from continuing operations, per basic share for fiscal 2024 was -$87.38.
- Aptevo Therapeutics Inc. income (loss) from continuing operations, per basic share for fiscal 2023 was -$2481.70, a 179933.33% decline from fiscal 2022.
- Aptevo Therapeutics Inc. income (loss) from continuing operations, per basic share for fiscal 2022 was $1.38.
- Aptevo Therapeutics Inc. income (loss) from continuing operations, per basic share for fiscal 2021 was -$6.27.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 12 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -$87.38 10-K · filed 2025-02-14 | |||||||
| 2024-09-30 | -$0.48 10-Q · filed 2024-11-07 | -$5.01 10-Q · filed 2024-11-07 | ||||||
| 2024-06-30 | -$1.67 10-Q · filed 2024-08-08 | -$6.02 10-Q · filed 2024-08-08 | ||||||
| 2024-03-31 | -$9.95 10-Q · filed 2024-05-08 | |||||||
| 2023-12-31 | -$2481.70 10-K · filed 2025-02-14 | -$1.52 10-K · filed 2024-03-05 | ||||||
| 2023-09-30 | -$22.16 10-Q · filed 2024-11-07 | -$0.50 10-Q · filed 2023-11-14 | -$60.84 10-Q · filed 2024-11-07 | -$1.38 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | -$53.95 10-Q · filed 2024-08-08 | -$1.23 10-Q · filed 2023-08-10 | -$37.45 10-Q · filed 2024-08-08 | -$0.85 10-Q · filed 2023-08-10 | ||||
| 2023-03-31 | $11.45 10-Q · filed 2024-05-08 | $0.26 10-Q · filed 2023-05-11 | ||||||
| 2022-12-31 | $1.38 10-K · filed 2024-03-05 | $1.37 10-K · filed 2023-03-30 | ||||||
| 2022-09-30 | -$1.53 10-Q · filed 2023-11-14 | $2.43 10-Q · filed 2023-11-14 | $2.42 10-Q · filed 2022-11-10 | |||||
| 2022-06-30 | $5.55 10-Q · filed 2023-08-10 | $4.01 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | -$1.59 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | -$6.27 10-K · filed 2023-03-30 | |||||||
| 2021-09-30 | -$1.45 10-Q · filed 2022-11-10 | -$4.94 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | -$1.78 10-Q · filed 2022-08-11 | -$3.51 10-Q · filed 2022-08-11 | ||||||
| 2018-09-30 | -$0.56 10-Q · filed 2018-11-14 | -$1.77 10-Q · filed 2018-11-14 | ||||||
| 2018-06-30 | -$0.58 10-Q · filed 2018-08-09 | -$1.21 10-Q · filed 2018-08-09 | ||||||
| 2018-03-31 | -$0.63 10-Q · filed 2018-05-10 | |||||||
| 2017-09-30 | $0.14 10-Q · filed 2018-11-14 | -$1.08 10-Q · filed 2018-11-14 | ||||||
| 2017-06-30 | -$0.67 10-Q · filed 2018-08-09 | -$1.23 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | -$0.56 10-Q · filed 2018-05-10 | |||||||
| 2016-09-30 | -$3.63 10-Q · filed 2017-11-13 | -$5.13 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |